PE20151589A1 - Proceso de fabricacion de vortioxetina - Google Patents

Proceso de fabricacion de vortioxetina

Info

Publication number
PE20151589A1
PE20151589A1 PE2015001720A PE2015001720A PE20151589A1 PE 20151589 A1 PE20151589 A1 PE 20151589A1 PE 2015001720 A PE2015001720 A PE 2015001720A PE 2015001720 A PE2015001720 A PE 2015001720A PE 20151589 A1 PE20151589 A1 PE 20151589A1
Authority
PE
Peru
Prior art keywords
vortioxetine
piperazine
manufacturing process
optionally substituted
decomplexes
Prior art date
Application number
PE2015001720A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PE20151589A1 publication Critical patent/PE20151589A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PE2015001720A 2013-02-22 2014-02-20 Proceso de fabricacion de vortioxetina PE20151589A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361767883P 2013-02-22 2013-02-22
DKPA201300104 2013-02-22

Publications (1)

Publication Number Publication Date
PE20151589A1 true PE20151589A1 (es) 2015-12-03

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001720A PE20151589A1 (es) 2013-02-22 2014-02-20 Proceso de fabricacion de vortioxetina

Country Status (37)

Country Link
US (1) US9353073B2 (OSRAM)
EP (1) EP2958903B1 (OSRAM)
JP (1) JP6464098B2 (OSRAM)
KR (1) KR102230628B1 (OSRAM)
CN (1) CN104995181B (OSRAM)
AP (1) AP2015008640A0 (OSRAM)
AU (1) AU2014220735B2 (OSRAM)
BR (1) BR112015019268B1 (OSRAM)
CA (1) CA2901821A1 (OSRAM)
CL (1) CL2015002309A1 (OSRAM)
CR (1) CR20150423A (OSRAM)
CY (1) CY1118883T1 (OSRAM)
DK (1) DK2958903T3 (OSRAM)
DO (1) DOP2015000187A (OSRAM)
EA (1) EA027756B1 (OSRAM)
ES (1) ES2625380T3 (OSRAM)
GE (1) GEP201706749B (OSRAM)
HR (1) HRP20170607T1 (OSRAM)
IL (1) IL240501B (OSRAM)
LT (1) LT2958903T (OSRAM)
MA (1) MA38338B1 (OSRAM)
ME (1) ME02671B (OSRAM)
MX (1) MX362355B (OSRAM)
MY (1) MY172337A (OSRAM)
PE (1) PE20151589A1 (OSRAM)
PH (1) PH12015501807B1 (OSRAM)
PL (1) PL2958903T3 (OSRAM)
PT (1) PT2958903T (OSRAM)
RS (1) RS55932B1 (OSRAM)
RU (1) RU2652265C2 (OSRAM)
SG (1) SG11201506651SA (OSRAM)
SI (1) SI2958903T1 (OSRAM)
SM (1) SMT201700238T1 (OSRAM)
TN (1) TN2015000335A1 (OSRAM)
UA (1) UA116236C2 (OSRAM)
WO (1) WO2014128207A1 (OSRAM)
ZA (1) ZA201506050B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2605652T3 (pl) 2010-08-18 2018-04-30 Samumed, Llc Diketony i hydroksyketony jako aktywatory szlaku sygnalizacji kateninowej
PE20151721A1 (es) 2013-02-22 2015-12-07 Samumed Llc Y-dicetonas como activadores de la ruta de senalizacion de wnt/b-catenina
KR102165385B1 (ko) 2014-08-20 2020-10-15 사뮤메드, 엘엘씨 피부 노화 및 주름의 치료 및 예방을 위한 감마-디케톤
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
CN109071374A (zh) * 2016-02-08 2018-12-21 Aaa化学公司 脂肪胺的芳基化
BR112018003930A2 (pt) 2016-07-01 2018-09-25 H Lundbeck As regimes de dosagem de vortioxetina para início rápido de efeito antidepressivo
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
CN100457738C (zh) * 2001-12-20 2009-02-04 H·隆德贝克有限公司 芳氧基苯基和芳硫基苯基衍生物
EP2439201B1 (en) * 2006-06-16 2013-08-07 H. Lundbeck A/S Compounds with combined sert, 5-ht3 and 5-ht1a activity
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
MX362355B (es) 2019-01-14
SG11201506651SA (en) 2015-09-29
CY1118883T1 (el) 2018-01-10
JP2016509042A (ja) 2016-03-24
BR112015019268A2 (pt) 2020-01-28
DK2958903T3 (en) 2017-05-15
EP2958903B1 (en) 2017-04-12
CA2901821A1 (en) 2014-08-28
TN2015000335A1 (en) 2017-01-03
ME02671B (me) 2017-06-20
US9353073B2 (en) 2016-05-31
SI2958903T1 (sl) 2017-09-29
GEP201706749B (en) 2017-10-10
WO2014128207A1 (en) 2014-08-28
JP6464098B2 (ja) 2019-02-06
HK1216098A1 (en) 2016-10-14
PH12015501807A1 (en) 2015-11-09
UA116236C2 (uk) 2018-02-26
PL2958903T3 (pl) 2017-08-31
CR20150423A (es) 2015-10-20
MY172337A (en) 2019-11-21
RS55932B1 (sr) 2017-09-29
KR102230628B1 (ko) 2021-03-22
MA38338A1 (fr) 2016-09-30
US20160009670A1 (en) 2016-01-14
CN104995181A (zh) 2015-10-21
PT2958903T (pt) 2017-05-26
EA201591349A1 (ru) 2015-12-30
AP2015008640A0 (en) 2015-08-31
CL2015002309A1 (es) 2016-03-04
AU2014220735B2 (en) 2017-06-22
MA38338B1 (fr) 2018-10-31
RU2015134407A (ru) 2017-03-28
LT2958903T (lt) 2017-08-25
MX2015010656A (es) 2015-12-17
EA027756B1 (ru) 2017-08-31
ZA201506050B (en) 2017-08-30
KR20150118146A (ko) 2015-10-21
RU2652265C2 (ru) 2018-04-27
EP2958903A1 (en) 2015-12-30
BR112015019268B1 (pt) 2023-01-10
DOP2015000187A (es) 2015-11-30
SMT201700238T1 (it) 2017-07-18
CN104995181B (zh) 2017-03-08
ES2625380T3 (es) 2017-07-19
AU2014220735A1 (en) 2015-08-20
HRP20170607T1 (hr) 2017-06-30
IL240501A0 (en) 2015-09-24
PH12015501807B1 (en) 2019-05-31
IL240501B (en) 2018-08-30

Similar Documents

Publication Publication Date Title
PE20151589A1 (es) Proceso de fabricacion de vortioxetina
BR112015019627A2 (pt) amidas heterocíclicas como inibidores de quinases
MX2014000556A (es) Compuesto heterociclico fusionado y su uso para el control de plagas.
CO7170165A2 (es) Fabricación de ácido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acético
CR20200276A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamientos de la hepatitis b (divisional exp. 2015-0059)
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
UY32096A (es) Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones
CO6430460A2 (es) Compuestos tetraciclicos
BR112015005694A2 (pt) pró-fármacos de inibidor amino-quinazoliníco de quinase
BR112015029399A2 (pt) produção em etapa única de uma composição de polipropileno
BR112012011064A2 (pt) novos compostos de diazinilpirazolila.
MX2015015906A (es) Mejoras en o con relacion a compuestos organicos.
MX2016000390A (es) Proceso para fabricar haloacetamidas.
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
MX2020009462A (es) Procesos para la preparación de compuestos de pirimidinilciclopentano.
AR089929A1 (es) Proceso para manufacturar un derivado de naftiridina
BR112012022928A2 (pt) beta-hidroxialquilamidas, processo para sua produção, bem como seu uso
AR095353A1 (es) Compuesto
CR20160165A (es) Acetato de 4-{4-[(1 e)-4-(2,9- diazaespiro [5.5] undec-2-il) but-1 -en-i -il]-2- metilbencil}-5-(propan-2-il) -1h-pirazol-3-ilo beta-d- glucopiranósido
PE20151334A1 (es) Metodo de produccion de compuestos de piridazinona
CY1120482T1 (el) Μεθοδος συνθεσης 3,4-διμεθοξυδικυκλο[4.2.0]οκτα-1,3,5-τριενο-7-καρβονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξy
ECSP15036884A (es) Proceso de fabricación de vortioxetina
BR112015019208A2 (pt) processo de síntese
BR112015028751A2 (pt) processo para a preparação de derivados de 3,5-bis (fluoralquil)pirazol a partir de alfa,alfa-dihaloaminas
AR096851A1 (es) Sales que no forman hidratos ni solvatos de nalmefeno

Legal Events

Date Code Title Description
FG Grant, registration